INFARMATIS, OOO, Moscow

Economic indicators

Net profit (RAS) of INFARMATIS, OOO grew over 2023 1.89 times to 445.00 thousand RUB from 235.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 18.54% to 34.35 million RUB from 28.98 million RUB over 2022; cost of goods sold grew by 35.32% to 29.15 million RUB from 21.55 million RUB; sales profit fell 4.17 times to 277.00 thousand RUB from 1.15 million RUB.

Net profit (RAS) of INFARMATIS, OOO dropped in 2022 5.97 times to 235.00 thousand RUB from 1.40 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 26.87% to 28.98 million RUB from 39.63 million RUB in 2021; cost of goods sold decreased by 24.50% to 21.55 million RUB from 28.54 million RUB; sales profit fell by 48.06% to 1.15 million RUB from 2.22 million RUB.

Net profit (RAS) of INFARMATIS, OOO grew over 2021 2.49 times to 1.40 million RUB from 563.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period 4.07 times to 39.63 million RUB from 9.74 million RUB over 2020; cost of goods sold grew 28.45 times to 28.54 million RUB from 1.00 million RUB; sales profit went up 1.71 times to 2.22 million RUB from 1.30 million RUB.

Net profit (RAS) of INFARMATIS, OOO dropped in 2020 3.63 times to 563.00 thousand RUB from 2.04 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period 1.63 times to 9.74 million RUB from 5.98 million RUB over 2019; sales profit fell by 40.39% to 1.30 million RUB from 2.18 million RUB.

Net profit (RAS) of INFARMATIS, OOO made up 2.04 million RUB over 2019 compared to net loss of 1.00 thousand RUB over 2018, the company informed.

Companies in the region

• RESURSPROM
• PARMA
• MODUL'
• PIKTA
• VELES